June 2019 - Evolution Biotechnologies
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Bedford, UK, June 7th, 2019 Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control to benefit human health, today received a letter of support from Asthma UK, the charity dedicated to improving the health and well-being of the 5.4 million people in the UK whose lives are affected by asthma. The letter was provided following a meeting with senior staff of the charity, and states: “Asthma UK welcomes your proposal, which seeks to establish a novel approach to remove triggers of asthma by targeting house dust mites through development of a biological control agent. People with asthma...